期刊文献+

乙型肝炎肝硬化患者血浆D-二聚体水平变化的临床意义 被引量:23

Clinical significance of the change in plasma D-dimer in patients with hepatitis B cirrhosis
下载PDF
导出
摘要 目的评估血浆D-二聚体水平与乙型肝炎肝硬化患者病情严重程度的相关性及诊断门静脉血栓形成(PVT)的价值。方法收集2018年1月-12月就诊于解放军第五医学中心的500例乙型肝炎肝硬化患者的临床资料,根据血浆D-二聚体水平是否正常分为正常组(n=217)和升高组(n=283),比较两组患者血浆D-二聚体水平与Child-Pugh分级、MELD评分的相关性。正态分布的计量资料两组间比较采用t检验。非正态分布的计量资料两组间比较采用Mann-Whitney U检验;多组间比较及进一步两两比较均采用Kruskal-Wallis H检验。计数资料两组间比较采用χ2检验。相关性分析采用Spearman相关分析。利用受试者工作特征曲线(ROC曲线)分析评价D-二聚体水平对乙型肝炎肝硬化患者PVT的早期预警效能。结果两组患者D-二聚体水平、ALT、AST、TBil、Alb、Child-Pugh分级、MELD评分、PVT发生率比较,差异均有统计学意义(P值均<0.05)。相关性分析结果显示,两组患者血浆D-二聚体水平与Child-Pugh分级、MELD评分均呈正相关(r值分别为0.463、0.455、0.214、0.756,P值均<0.05)。共50例乙型肝炎肝硬化患者合并PVT,PVT阳性患者的D-二聚体水平明显高于PVT阴性患者[1.96(0.82~4.91)mg/L vs 0.61(0.19~1.54)mg/L,Z=-6.02,P<0.001]。ROC曲线分析结果显示,最佳诊断界值为0.76 mg/L,ROC曲线下面积和95%可信区间为0.758(0.719~0.796)。结论D-二聚体水平与乙型肝炎肝硬化患者的病情严重程度密切相关,可作为判断乙型肝炎肝硬化患者预后的指标。对于D-二聚体水平升高的患者,需警惕PVT的可能。 Objective To investigate the correlation between plasma D-dimer level and severity of hepatitis B cirrhosis and its value in the diagnosis of portal vein thrombosis(PVT).Methods A retrospective analysis was performed for the clinical data of 500 patients with hepatitis B cirrhosis who were hospitalized in The Fifth Medical Center of Chinese PLA General Hospital from January to December,2018,and according to the plasma level of D-dimer,they were divided into normal group with 217 patients and elevated group with 283 patients.The correlations of plasma D-dimer level with Child-Pugh class and Model for End-Stage Liver Disease(MELD)score were compared between the two groups.The t-test was used for comparison of normally distributed continuous data between two groups,and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups;the Kruskal-Wallis H test was used for multiple groups comparison and further pairwise comparison.The chi-square test was used for comparison of categorical data between two groups.A Spearman correlation analysis was used to investigate correlation.The receiver operating characteristic(ROC)curve was used to evaluate the early warning performance of D-dimer level for PVT in patients with hepatitis B cirrhosis.Results There were significant differences between the two groups in D-dimer level,alanine aminotransferase,aspartate aminotransferase,total bilirubin,albumin,Child-Pugh class,MELD score,and incidence rate of PVT(all P<0.05).The correlation analysis showed that plasma D-dimer level was positively correlated with Child-Pugh class and MELD score in both groups(r=0.463,0.455,0.214,and 0.756,all P<0.05).A total of 50 patients with hepatitis B cirrhosis were found to have PVT;the patients with PVT had a significantly higher D-dimer level that those without PVT[1.96(0.82-4.91)mg/L vs 0.61(0.19-1.54)mg/L,Z=-6.02,P<0.001].The ROC curve analysis showed that D-dimer level had an area under the ROC curve of 0.758(95%confidence interval:0.719-0.796)at the optimal cut-off value of 0.76 mg/L.Conclusion Plasma D-dimer level is correlated with the severity of hepatitis B cirrhosis and can be used to predict the prognosis of patients with hepatitis B cirrhosis.The possibility of PVT should be considered in patients with an elevated D-dimer level.
作者 徐静 纪冬 王春艳 付懿铭 陈松海 李忠斌 陈国凤 XU Jing;JI Dong;WANG Chunyan(Second Ward of Department of Liver Diseases,Fuyang Second People’s Hospital,Fuyang,Anhui 236000,China)
出处 《临床肝胆病杂志》 CAS 北大核心 2020年第3期551-555,共5页 Journal of Clinical Hepatology
基金 首都临床特色应用研究特色课题(Z181100001718034) 菊梅肝胆病防治能力建设专项基金重点项目(2018JM12603003) 中国肝炎防治基金会王宝恩肝纤维化研究基金重点项目(2011xjs0408)。
关键词 肝炎 乙型 肝硬化 D-二聚体 早期诊断 hepatitis B liver cirrhosis D-dimer early diagnosis
  • 相关文献

参考文献6

二级参考文献84

  • 1Mats gren,David Bergqvist,Martin Bjrck,Stefan Acosta,Henry Eriksson,Nils H Sternby.Portal vein thrombosis:Prevalence,patient characteristics and lifetime risk:A population study based on 23796 consecutive autopsies[J].World Journal of Gastroenterology,2006,12(13):2115-2119. 被引量:69
  • 2Lai CL,Shouval D,Lok AS,陈楠(摘译),张占卿(审校).恩替卡韦与拉米夫定治疗HBeAg阴性慢性乙型肝炎的对照研究[J].世界感染杂志,2006,6(4):396-396. 被引量:201
  • 3梅斌,郑凯,陈孝平.断流术后门静脉血栓形成与血小板膜蛋白CD62P的关系[J].华中科技大学学报(医学版),2006,35(4):548-549. 被引量:38
  • 4张琴,刘平,章浩伟,王磊,都广礼,陈慧芬,陈良,王江容,王宪波.900例肝炎后肝硬化中医证候判别模式的研究[J].中国中西医结合杂志,2006,26(8):694-697. 被引量:63
  • 5Blei AT. Diagnosis and treatment of hepatic encephalopathy.Baillieres Best Pract Res Clin Gastroenterol 2000; 14: 959-974[PMID: 11139349 DOI: 10.1053/bega.2000.0141].
  • 6Malaguarnera M, Pistone G, Astuto M, Vecchio I, RaffaeleR, Lo Giudice E, Rampello L. Effects of L-acetylcarnitine oncirrhotic patients with hepatic coma: randomized double-blind,placebo-controlled trial. Dig Dis Sci 2006; 51: 2242-2247 [PMID:17080254 DOI: 10.1007/s10620-006-9187-0].
  • 7Malaguarnera M, Risino C, Cammalleri L, Malaguarnera L,Astuto M, Vecchio I, Rampello L. Branched chain amino acidssupplemented with L-acetylcarnitine versus BCAA treatment inhepatic coma: a randomized and controlled double blind study.Eur J Gastroenterol Hepatol 2009; 21: 762-770 [PMID: 19357525DOI: 10.1097/MEG.0b013e328309c791].
  • 8Donovan JP, Schafer DF, Shaw BW, Sorrell MF. Cerebral oedemaand increased intracranial pressure in chronic liver disease. Lancet1998; 351: 719-721 [PMID: 9504517 DOI: 10.1016/S0140-6736(97)07373-X].
  • 9Malaguarnera M, Vacante M, Russo C, Gargante MP, GiordanoM, Bertino G, Neri S, Malaguarnera M, Galvano F, Li Volti G.Rosuvastatin reduces nonalcoholic fatty liver disease in patientswith chronic hepatitis C treated with α-interferon and ribavirin:Rosuvastatin reduces NAFLD in HCV patients. Hepat Mon 2011;11: 92-98 [PMID: 22087124].
  • 10Malaguarnera M, Drago F, Malaguarnera G, Li Volti G, SalomoneS, Caraci F, Galvano F, Vacante M, Bucolo C, Malaguarnera M.Metal fume fever. Lancet 2013; 381: 2298 [PMID: 23809563 DOI:10.1016/S0140-6736(13)60689-3].

共引文献1124

同被引文献273

引证文献23

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部